Skip to contentP
PDS Biotechnology Corp
P
PDSBPDS Biotechnology Corp Released Mar 27, 2025, before the open
10-K filed Mar 27, 2025, 86 days after period end · 0001140361-25-010717
Q4 2024 · 10-K
Revenue—
Net Income-$7.95M-$7.95MN/M vs Q4 2023N/M vs Q3 2024 EPS, diluted
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
—
Operating Incomederived-$7,360,570N/M Operating Cash Flowderived-$8,234,439N/M Free Cash Flowderived-$8,234,439N/M ended Dec 31, 2024 · filed Mar 27, 2025 · 86 d after period end
+1.6% from the close of Mar 26, 2025 to the close of Mar 27, 2025, the first after the release.
before the open$1.24$1.26 Mar 5Mar 27Apr 17